ArticleBMC public health2025
Women's experiences of changes in related men's impulsivity and domestic violence following men's participation in the ReINVEST clinical trial.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundImpulsivity, a behaviour often associated with reactive violence to perceived provocation or stress is a key risk factor for Domestic Violence (DV) perpetration. This study explores the experiences of women on related men's changes in impulsivity and DV following men's participation in the ReINVEST clinical trial that investigated whether the commonly used antidepressant sertraline would reduce impulsivity and domestic violence.
methodsThe study conducted in-depth interviews with 27 women ex(partners) and family members living in New South Wales, Australia. Critical Realism and Self-Determination Theory (SDT) underpinned the analysis and interpretation of findings.
resultsMost women (92.3%, n = 24) reported some or significant changes in impulsivity and DV or intimate partner violence (IPV) following the participation of related men in the trial. Many changes were reported at the individual (e.g., self-regulation), partner or family (e.g., feeling safer), and social levels (e.g., employment). Analysis using critical realism and SDT identified three themes (Determination to change, Enabling environment, and Continuum of changes) that illustrated the underlying mechanisms and causal explanations of the changes women experienced among themselves and the trial participants.
conclusionsThe experiences of women revealed the benefit of antidepressant sertraline in reducing impulsivity and DV or IPV when supported with other interventions (e.g., counselling and follow-up support by clinicians). The behaviour change processes described using critical realism and Self-Determination Theory (SDT) demonstrated the potential of SDT-grounded approaches in reducing impulsivity and its associated effects on intimate partner violence (IPV) or domestic violence (DV).
trial registrationAustralian New Zealand Clinical Trials Registry, ACTRN12613000442707, registered on 18/04/2013.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.